FABP6 serves as a new therapeutic target in esophageal tumor.

Interestingly, no significant change was observed in exhausted T cell infiltration, suggesting that the efficacy of PD-1 may not be significant in esophageal tumors.

also in 2,774 other papers

In recent years, it has shown an increasing trend and tends to affect younger individuals.

also in 63,971 other papers